2026 NPPES data Podiatrist NPI 1932153970 DPM
Verify on CMS →

ILAN BAZAK, DPM

Podiatrist in LOS ANGELES, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 383 beneficiaries · Podiatrist avg: 304
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$800.5
11 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ILAN BAZAK, DPM is a Podiatrist ([object Object]) practicing in LOS ANGELES, California with a Medicare Part D prescribing footprint of 2K claims across 383 beneficiaries — 12% brand-name prescribing . Their CMS MIPS Final Score of 75/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $800.5 across 11 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ILAN BAZAK, DPM reported a CMS MIPS final score of 75 out of 100, below the 83.1 national average, and filed 1,802 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ILAN BAZAK, DPM at a glance

Below national average

NPI registry status

Active

Issued 05/22/2006

NPI 1932153970

Primary specialty

Podiatrist

Mid-sized

10,498 US NPIs in this specialty

Medicare Part D claims

1,802 493% vs specialty avg

2023 prescription claims

Specialty avg: 304

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Podiatrist compares to other specialties among California providers

California providers

Podiatrist share within California

1. Podiatrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Podiatrist share within California

Medicare quality performance — MIPS

ILAN BAZAK, DPM's 2023 MIPS final score plotted against the Podiatrist national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Podiatrist) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Podiatrist) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ILAN BAZAK, DPM is a Podiatrist provider practicing in LOS ANGELES, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: DPM. NPI: 1932153970. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ILAN BAZAK, DPM appears in the CMS NPPES registry as a Podiatrist provider holding DPM credentials at 1121 N FAIRFOX AVE, LOS ANGELES, CA, 90046, with a listed phone of (323) 650-6363. NPI 1932153970 was issued on 05/22/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BAZAK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,802 prescription claims written by this provider, covering 383 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 0.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Podiatrist is a mid-sized specialty nationwide, with 10,498 enrolled providers across 54 states and an average of 304 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1121 N FAIRFOX AVE
LOS ANGELES, CA 90046

Provider Details

NPI 1932153970
Specialty Podiatrist
Credentials DPM
Gender Male
NPI Issued 05/22/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ILAN BAZAK, DPM. Source: openpaymentsdata.cms.gov.

Total received

$801

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ILAN BAZAK, DPM. To verify ILAN BAZAK, DPM's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ILAN BAZAK, DPM — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 1,802 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,802
Total Claims
$1.0M
Total Drug Cost
383
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,830
Total Day Supply
52,414
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$153K
Generic Drug Cost
$864K
Opioid Claims
16 (0.9% rate)
Antibiotic Claims
49

Patient Demographics

Average Patient Age
77.8 years
Avg HCC Risk Score
1.73
Gender Split
61% female / 39% male
Age Distribution
<65: 21, 65-74: 119, 75-84: 139, 85+: 104

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tavaborole
772
Oxiconazole Nitrate
135
Diflorasone Diacetate
117
Diclofenac Sodium
99
Jublia
Efinaconazole
90
Mupirocin
63
Naproxen-Esomeprazole Mag
Naproxen/Esomeprazole Mag
53
Econazole Nitrate
47
Meloxicam
43
Ciclopirox
Ciclopirox Olamine
29

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Podiatrist Overview

How ILAN BAZAK, DPM fits within the Podiatrist landscape nationally.

10,498
Podiatrist Providers in US
54
States with Podiatrist
304
Avg Claims per Provider

ILAN BAZAK, DPM's 1,802 claims are above the specialty average of 304.

Nearby Podiatrist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BAZAK.

Compare Podiatrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ILAN BAZAK, DPM's specialty?
ILAN BAZAK, DPM specializes in Podiatrist and practices in LOS ANGELES, California. Credentials: DPM.
How much does ILAN BAZAK, DPM prescribe under Medicare Part D?
In 2023, ILAN BAZAK, DPM wrote 1,802 Medicare Part D claims totaling $1.0M in drug costs for 383 beneficiaries.
What is ILAN BAZAK, DPM's Medicare quality score?
ILAN BAZAK, DPM has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ILAN BAZAK, DPM located?
ILAN BAZAK, DPM is located at 1121 N FAIRFOX AVE, LOS ANGELES, CA, 90046. Phone: (323) 650-6363.
What is ILAN BAZAK, DPM's NPI number?
ILAN BAZAK, DPM's National Provider Identifier (NPI) is 1932153970, issued on 05/22/2006.
Does ILAN BAZAK, DPM prescribe more brand-name or generic drugs?
ILAN BAZAK, DPM's prescribing is 12% brand-name and 88% generic drugs by claim count, with $153K in brand drug costs.
Does ILAN BAZAK, DPM prescribe opioids?
Yes, ILAN BAZAK, DPM had 16 opioid claims in 2023 with an opioid prescribing rate of 0.9%.
How many Podiatrist providers are there in the US?
There are 10,498 Podiatrist providers across 54 states in the US. The average Podiatrist provider writes 304 Medicare Part D claims per year.
What drugs does ILAN BAZAK, DPM prescribe most often?
Based on 2023 Medicare Part D data, ILAN BAZAK, DPM's most frequently prescribed drugs include Tavaborole, Oxiconazole Nitrate, Diflorasone Diacetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ILAN BAZAK, DPM accept Medicare?
ILAN BAZAK, DPM appears in CMS Medicare data with 1,802 Part D claims and 383 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ILAN BAZAK, DPM's credentials?
ILAN BAZAK, DPM's NPI is 1932153970 with credentials DPM. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology